healthcarenewswire

According to P&S Intelligence, global organ-on-chip market size is forecasted to reach $163.1 million by 2025. The growth in the market will be led by the rising need for effective drug discovery and development, increasing demand for alternatives for animal models in research, increasing drug repurposing approaches, and government grants and funds for research.

Get report sample at: http://bit.ly/2GXdjho

Organ-on-chip products find application in toxicology research, physiological model development, and drug discovery. The application of organ-on-chip for drug discovery is projected to witness fastest growth in demand, registering CAGR of 47.7% during the forecast period. On the basis of end user, the adoption of organ-on-chip by pharmaceutical and biotechnology companies is higher as compared to academic & research institutes, and other end users since a majority of grants and investments for research and development are received by these companies.

The organ-on-chip market in APAC is expected to witness a significant growth during the forecast period. This growth is attributed to factors such as increasing healthcare expenditure, rising government initiatives and funding for healthcare R&D, and increase in the adoption of advanced technologies in the region.

The players in organ-on-chip market are launching new and innovative products to enhance their product portfolio. For instance, in July 2017, Hmrel Corporation, launched HuRELviral application. The Hµrelviral microliver testing platform sustains hepatitis B virus (HBV) infection in actual human liver cells for over thirty days. This is expected to equip virologists with unprecedented insight into a drug candidate’s potential to cure chronic HBV.

Furthermore, in February 2017, InSphero AG introduced the GravityTRAP 384 Microtissue Platform at the Society for Laboratory Automation and Screening (SLAS) 2017 Conference. The GravityTRAP 384 platform features distinct microtissue culture and media chambers separated by a tapered SureXchange pipetting ledge, and a continuous flat-bottomed glass base plate combined with a black-walled body, ensuring superior confocal and high content imaging optics while reducing fluorescent cross-talk between wells.

Some of the other key players operating in the organ-on-chip industry include Emulate Inc., Mimetas B.V., TissUse GmbH, Kirkstall Ltd., CN Bio Innovations Ltd, Ascendance Biotechnology, Inc., Nortis, Inc., and Organovo Holdings, Inc.

Source: P&S Intelligence